Evidence map›Paper›PMID 32984380›Full record

ArticleFrontiers in medicine2020

Advocacy for Increased International Efforts for Antimicrobial Stewardship Actions in Low-and Middle-Income Countries on Behalf of Alliance for the Prudent Use of Antimicrobials (APUA), Under the Auspices of the International Society of Antimicrobial Chemotherapy (ISAC).

Pierre Tattevin, Gabriel Levy Hara, Adnene Toumi, Mushira Enani, Geoffrey Coombs, Andreas Voss, Heiman Wertheim, Armel Poda, Ziad Daoud, Ramanan Laxminarayan and 2 more

Abstract read
In one paragraph

Article in Frontiers in medicine, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Review
  9. Review
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Pierre TattevinInfectious Diseases and Intensive Care Unit, Pontchaillou University Hospital Center, Rennes, France.
Gabriel Levy HaraInfectious Diseases Unit, Hospital Carlos G. Durand, Buenos Aires, Argentina.
Adnene ToumiInfectious Diseases Department, Monastir University Hospital, Monastir, Tunisia.
Mushira EnaniFaculty of Medicine, King Fahad Medical City, Riyadh, Saudi Arabia.
Geoffrey CoombsAntimicrobial Resistance and Infectious Diseases Research Laboratory, Murdoch University, Perth, WA, Australia.
Andreas VossDepartment of Medical Microbiology and Infectious Diseases, Canisius-Wilhelmina Hospital, Nijmegen, Netherlands.
Heiman WertheimRadboudumc, Department of Medical Microbiology and Radboud Center for Infectious Diseases, Nijmegen, Netherlands.
Armel PodaInfectious Diseases Department, Sourô Sanou University Hospital, Bobo-Dioulasso, Burkina Faso.
Ziad DaoudClinical Microbiology, Saint George Hospital-UMC and University of Balamand, Beirut, Lebanon.
Ramanan LaxminarayanCenter for Disease Dynamics, Economics and Policy (CDDEP), New Delhi, India.
Dilip NathwaniNinewells Hospital and Medical School, Dundee, United Kingdom.
Ian GouldAberdeen Royal Infirmary, Aberdeen, United Kingdom.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Antimicrobial stewardship (AMS) is a set of coordinated strategies to improve the use of antimicrobials, to enhance patient outcomes, reduce antimicrobial resistance, and decrease unnecessary costs. The pioneer years of AMS were restricted to high-income countries (HIC), where overconsumption of antibiotics was associated with emergence of multidrug-resistant (MDR) bacteria. AMS in low- and middle-income countries (LMIC) is also necessary. However, programs effective in HIC may not perform as well in LMIC, because (i) While decreased consumption of antibiotics may be an appropriate target in overconsuming HIC, this may be dangerous in LMIC, where many patients die from the lack of access to antibiotics; (ii) although AMS programs in HIC can be designed and monitored through laboratory surveillance of resistance, surveillance programs are not available in many LMIC; (iii) the heterogeneity of health care systems implies that AMS programs must be carefully contextualized. Despite the need to individually tailor AMS programs in LMIC, international collaborations remain highly valuable, through the dissemination of high-quality documents and educational material, that may be shared, adapted where needed, and adopted worldwide. This process, facilitated by modern communication tools, combines many benefits, including: (i) saving time, a precious dimension for health care workers, by avoiding the duplication of similar works in different settings; (ii) taking advantage of colleagues skills, and initiatives, through open access to the work performed in other parts of the world; (iii) sharing experiences, so that we all learn from each others' successes and failures.

Indexed as

antibioticsantimicrobial stewardshipeducationlow- and middle- income countriesresistance

Identifiers

PMID32984380
PMCPMC7479847

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.